SCHEMBL28518021

SCHEMBL28518021

CCCCCc1ncc(C(O)=S)c(NCc2ccccc2)n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 3/20 0.56
▸ PDE4B Q07343 3/20 0.56
▸ PDE4C Q08493 3/20 0.56
▸ PDE4D Q08499 3/20 0.56
▸ PDE3B Q13370 2/20 0.56
▸ PDE3A Q14432 2/20 0.56
▸ AGTR1 P30556 8/20 0.55
▸ AGTR2 P50052 8/20 0.55
▸ JAK2 O60674 1/20 0.45
▸ JAK1 P23458 1/20 0.45
▸ JAK3 P52333 1/20 0.45
▸ SIRT5 Q9NXA8 2/20 0.44
▸ MEN1 O00255 2/20 0.43
▸ LMNA P02545 2/20 0.43
▸ POLB P06746 2/20 0.43
▸ HTT P42858 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28522379 0.90 PDE4A (0.53) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL28518880 0.88 AGTR1 (0.55) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL34462302 0.71 AGTR1 (0.51) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL28524820 0.70 ALDH1A1 (0.44) MEN1LMNAPOLBHTTKMT2A
SCHEMBL28518019 0.69 PPARG (0.62) AGTR1AGTR2MAPTSMN1; SMN2
SCHEMBL28511100 0.65 RARB (0.39) MEN1LMNAKMT2AALDH1A1MAPT
Hydrochloric Acid SCHEMBL4468113 0.65 NPSR1 (0.51) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL16145817 0.64 PDE4A (0.56) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL9913720 0.64 ALDH1A1 (0.68) MEN1LMNAPOLBHTTKMT2A
SCHEMBL4557233 0.63 TLR8 (0.50) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106279044-B Pyrimidine hydroxamic acid derivative and preparation method and application thereof 厦门市博瑞来医药科技有限公司 2021-02-19 — — CN disclosed
Send feedback